|
TLSI TriSalus Life Sciences Inc 1826667 |
| Balance Sheet |
|
Current Assets
|
$68,138,000.00 |
|
Assets
|
$70,979,000.00 |
|
Current Liabilities
|
$11,786,000.00 |
|
Liabilities
|
$58,172,000.00 |
|
Equity
|
$12,807,000.00 |
|
Shares Out
|
61414355.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,480,000.00 |
|
Investing Cash Flow
|
$-141,000.00 |
| Market Analysis |
Market Cap
|
$280,049,458.80 |
|
Price
|
$4.46 |
|
BVPS
|
0.21 |
|
PB
|
21.71 |
|
EPS
|
0.03 |
|
PS
|
8.09 |
|
FCF
|
$-6,621,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:31 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.21 |
|
|
2026-05-12 |
0.03 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.27 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.96 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TLSI documents filed with the SEC.
TLSI Filings
Clear
